Medpace Holdings Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Medpace Holdings stock has a consensus rating of "Hold" and an average price target of $443.5. The average 1-year stock price forecast is 18.41% lower than the current stock price, while the lowest is $329 (-39.47%) and the highest is $495 (-8.94%).

Price Target: $443.5 (-18.41%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$329	$443.5	$456	$495
Change	-39.47%	-18.41%	-16.11%	-8.94%

Analyst Ratings

The average analyst rating for Medpace Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	3	3	3	3	3
Buy	0	0	1	1	1	1
Hold	8	7	8	8	8	8
Sell	1	2	0	1	1	0
Strong Sell	3	1	1	0	0	1
Total	13	13	13	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Windley Jefferies	Jefferies	Buy Maintains $490	Buy	Maintains	$490	-9.86%	Jun 15, 2026
Sean Dodge BMO Capital	BMO Capital	Hold Reiterates $400	Hold	Reiterates	$400	-26.41%	Apr 24, 2026
Ryan Halsted RBC Capital	RBC Capital	Buy Reiterates $522 → $484	Buy	Reiterates	$522 → $484	-10.96%	Apr 24, 2026
Eric Coldwell Robert W. Baird	Robert W. Baird	Buy Maintains $565 → $477	Buy	Maintains	$565 → $477	-12.25%	Apr 24, 2026
Luke Sergott Barclays	Barclays	Hold Maintains $500 → $450	Hold	Maintains	$500 → $450	-17.21%	Apr 24, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

2.77B

from 2.53B

9.64%

from 2.53B

Revenue Next Year

2.95B

from 2.77B

6.23%

from 2.77B

EPS This Year

17.07

from 15.28

11.73%

from 15.28

EPS Next Year

18.76

from 17.07

9.89%

from 17.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.14B	1.46B	1.89B	2.11B	2.53B	2.77B
Revenue Growth	23.38%	27.80%	29.17%	11.84%	19.97%	9.64%
Operating Income	198.62M	278.70M	336.83M	446.87M	534.94M	580.73M
Net Income	181.85M	245.37M	282.81M	404.39M	451.12M	492.33M
EPS	-	-	-	-	15.28	17.07
EPS Growth	-	-	-	-	20.60%	11.73%
Forward PE	42.23	27.33	31.74	27.33	33.86	31.84
Free Cash Flow	214.38M	296.41M	346.29M	464.59M	472.38M	572.42M
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	2.8B
Avg	2.8B
Low	2.7B

Revenue Growth

Revenue Growth	2026	2027	2028
High	11.7%
Avg	9.6%
Low	7.6%

EPS Forecast

EPS	2026	2027	2028
High	17.78
Avg	17.07
Low	16.70

EPS Growth

EPS Growth	2026	2027	2028
High	16.4%
Avg	11.7%
Low	9.3%